Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 123

1.

Human immunodeficiency virus serotyping on dried serum spots as a screening tool for the surveillance of the AIDS epidemic.

Barin F, Plantier JC, Brand D, Brunet S, Moreau A, Liandier B, Thierry D, Cazein F, Lot F, Semaille C, Desenclos JC.

J Med Virol. 2006;78 Suppl 1:S13-8.

PMID:
16622871
2.

Synthetic peptide ELISAs for detection of and discrimination between group M and group O HIV type 1 infection.

Mauclère P, Damond F, Apetrei C, Loussert-Ajaka I, Souquière S, Buzelay L, Dalbon P, Jolivet M, Mony Lobe M, Brun-Vézinet F, Simon F, Barin F.

AIDS Res Hum Retroviruses. 1997 Aug 10;13(12):987-93.

PMID:
9264285
3.

Development and validation of an immunoassay for identification of recent human immunodeficiency virus type 1 infections and its use on dried serum spots.

Barin F, Meyer L, Lancar R, Deveau C, Gharib M, Laporte A, Desenclos JC, Costagliola D.

J Clin Microbiol. 2005 Sep;43(9):4441-7.

4.

Preliminary results from the new HIV surveillance system in France.

Lot F, Semaille C, Cazein F, Barin F, Pinget R, Pillonel J, Desenclos JC.

Euro Surveill. 2004 Oct;9(10):34-7.

PMID:
15507728
5.

Group o human immunodeficiency virus type 1 infection that escaped detection in two immmunoassays.

Zouhair S, Roussin-Bretagne S, Moreau A, Brunet S, Laperche S, Maniez M, Barin F, Harzic M.

J Clin Microbiol. 2006 Feb;44(2):662-5.

6.

Evolution of human immunodeficiency virus type 1 serotypes in northern Tanzania: a retrospective study.

Nyombi BM, Nkya W, Barongo L, Bjune G, Kristiansen KI, Müller F, Holm-Hansen C.

APMIS. 2008 Jun;116(6):507-14.

PMID:
18754325
7.

Serological and virological characterization of HIV-1 group O infection in Cameroon.

Mauclère P, Loussert-Ajaka I, Damond F, Fagot P, Souquières S, Monny Lobe M, Mbopi Keou FX, Barré-Sinoussi F, Saragosti S, Brun-Vézinet F, Simon F.

AIDS. 1997 Mar 15;11(4):445-53.

PMID:
9084791
8.

Serotyping and genotyping of HIV-1 infection in residents of Khayelitsha, Cape Town, South Africa.

Jacobs GB, de Beer C, Fincham JE, Adams V, Dhansay MA, van Rensburg EJ, Engelbrecht S.

J Med Virol. 2006 Dec;78(12):1529-36.

PMID:
17063507
9.

Monitoring the dynamics of the HIV epidemic using assays for recent infection and serotyping among new HIV diagnoses: experience after 2 years in France.

Semaille C, Barin F, Cazein F, Pillonel J, Lot F, Brand D, Plantier JC, Bernillon P, Le Vu S, Pinget R, Desenclos JC.

J Infect Dis. 2007 Aug 1;196(3):377-83. Epub 2007 Jun 19.

PMID:
17597452
10.

Human immunodeficiency virus (HIV) subtype surveillance of African-born persons at risk for group O and group N HIV infections in the United States.

Sullivan PS, Do AN, Ellenberger D, Pau CP, Paul S, Robbins K, Kalish M, Storck C, Schable CA, Wise H, Tetteh C, Jones JL, McFarland J, Yang C, Lal RB, Ward JW.

J Infect Dis. 2000 Feb;181(2):463-9.

PMID:
10669327
11.

High specificity of V3 serotyping among human immunodeficiency virus type-1 subtype C infected patients with varying disease status and viral phenotype.

Walker PR, Cilliers T, Choge IA, Taylor N, Cohen SS, Morris L.

J Med Virol. 2006 Oct;78(10):1262-8.

PMID:
16927278
12.

Application of dried blood spot specimens for serologic subtyping of human immunodeficiency virus type 1 in Thailand.

Chanbancherd P, Brown AE, Trichavaroj R, Tienamporn P, Puthakird P, Limpairojn N, VanCott TC, de Souza MS.

J Clin Microbiol. 1999 Mar;37(3):804-6.

13.

Serological detection of infection with diverse human and simian immunodeficiency viruses using consensus env peptides.

Masciotra S, Rudolph DL, van der Groen G, Yang C, Lal RB.

Clin Diagn Lab Immunol. 2000 Jul;7(4):706-9.

14.

Detection and differentiation of HIV-1 group O sera from HIV-1 group M and HIV-2 using recombinant antigens and peptides.

Hickman RK, Vallari A, Golden A, Lund J, Hackett J Jr, Brennan C, Devare S.

J Virol Methods. 1998 May;72(1):43-9.

PMID:
9672131
16.

V3 serotyping of HIV-1 infection: correlation with genotyping and limitations.

Plantier JC, Damond F, Lasky M, Sankalé JL, Apetrei C, Peeters M, Buzelay L, M'Boup S, Kanki P, Delaporte E, Simon F, Barin F.

J Acquir Immune Defic Syndr Hum Retrovirol. 1999 Apr 15;20(5):432-41.

PMID:
10225224
17.

Genetic variability of principal neutralizing determinants on HIV-1 gp41 and its correlation with subtypes.

Dong XN, Ying J, Wu Y, Chen YH.

Immunol Lett. 2005 Oct 15;101(1):104-7.

PMID:
15961163
18.

HIV global surveillance: foundation for retroviral discovery and assay development.

Brennan CA, Bodelle P, Coffey R, Harris B, Holzmayer V, Luk KC, Swanson P, Yamaguchi J, Vallari A, Devare SG, Schochetman G, Hackett J Jr.

J Med Virol. 2006;78 Suppl 1:S24-9.

PMID:
16622874
19.

Evaluation of the dried blood spot filter paper technology and five testing strategies of HIV-1 and HIV-2 infections in West Africa.

Sarge-Njie R, Schim Van Der Loeff M, Ceesay S, Cubitt D, Sabally S, Corrah T, Whittle H.

Scand J Infect Dis. 2006;38(11-12):1050-6.

PMID:
17148076
20.

[Serotypes of the human immunodeficiency virus type 1 in Madrid].

Soriano V, Dietrich U, Mas A, Andersen R, Bravo R, Ruppach H, Gutiérrez M, Martínez-Zapico R, Rübsamen-Waigmann H, González-Lahoz J.

Med Clin (Barc). 1997 Feb 15;108(6):217-20. Spanish.

PMID:
9102487

Supplemental Content

Support Center